03/03
Headlines

CORT

NASDAQ Insider Buying: Bazaarvoice Inc (NASDAQ:BV), Seattle Genetics (NASDAQ:SGEN), Corcept Therapeutics Incorporated (NASDAQ:CORT), Career Education (NASDAQ:CECO), Acorn Energy (NASDAQ:ACFN)

Kristen Barton03 mins

Bazaarvoice Inc (NYSE:BV) President Eugene Austin purchased 10,000 shares of the company’s stock on the open market in a transaction dated Monday, June 9th. The stock was purchased at an average price of $7.05 per share, with a total value of $70,500.00. Following the acquisition, the president now directly owns 260,000 shares in the company,…

Read More

Hot Watch List: BlackBerry Ltd (NASDAQ:BBRY), RF Micro Devices (NASDAQ:RFMD), Canadian Solar Inc. (NASDAQ:CSIQ), Corcept Therapeutics (NASDAQ:CORT)

Adam Keintzel02 mins

BlackBerry Ltd (NASDAQ:BBRY) is making good progress in its turnaround. According to a report from RBC Capital Markets, published on May 5, 2014, things are looking much better at the Canadian firm, “with the restructuring achieved” a quarter earlier, and also hardware profitability now “seeming within reach”. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -4.95% in…

Read More

Healthcare Watch List: Oncothyreon (NASDAQ:ONTY), Corcept Therapeutics Incorporated (NASDAQ:CORT), Aastrom Biosciences (NASDAQ:ASTM), Durata Therapeutics (NASDAQ:DRTX)

Colin Pettis02 mins

Corcept Therapeutics (NASDAQ:CORT) Director Longitude Venture Partners L.P sold 250,000 shares of the company’s stock on the open market in a transaction dated Friday, May 2nd. The stock was sold at an average price of $4.11, for a total value of $1,027,500.00. Corcept Therapeutics Incorporated (NASDAQ:CORT) rose 5.06% percent to $ 4.15 yesterday on volume…

Read More

Biotech Bearish Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Corcept Therapeutics Incorporated (NASDAQ:CORT), Puma Biotechnology Inc (NYSE:PBYI), Conatus Pharmaceuticals (NASDAQ:CNAT)

Mark DeFrance02 mins

A Palo Alto startup will focus an $18 million VC investment on developing a drug to stop unexplained recurrent miscarriages. Nora Therapeutics is capitalizing on work started by cofounder Darryl Carter at Johns Hopkins University that led to development of Nora’s lead drug, NT-100. Nora is led by CEO Jeff Tong, who had been vice…

Read More

Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Colin Pettis02 mins

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), just announced a positive, top-line result in a Phase 2 clinical trial of their experimental therapy LX4211 in type 1 diabetes. LX4211, an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2, was designed to lower blood glucose levels through two insulin-independent mechanisms of action. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)…

Read More

Healthcare bearish Stocks: Corcept Therapeutics Incorporated (NASDAQ:CORT), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), OXiGENE Inc (NASDAQ:OXGN), Depomed Inc (NASDAQ:DEPO)

Jason Knox02 mins

Corcept Therapeutics, Inc. (NASDAQ:CORT) entered into a manufacturing agreement (the “Agreement”) with AAIPharma Services Corp. (“AAI”), pursuant to which AAI will manufacture and package Korlym® tablets (the “product”). AAI will manufacture the product in accordance with FDA and other regulatory requirements. Corcept Therapeutics Incorporated (NASDAQ:CORT) stock performance was -6.85% in last session and finished the…

Read More